Dawn L. DeMeo, MD, MPH is a Respiratory/Genetic Epidemiologist at the Channing Division of Network Medicine and a trained Pulmonary/Critical Care Physician; she is an Associate Physician in the Department of Medicine at Brigham and Women’s Hospital and an Associate Professor of Medicine at Harvard Medical School. Her primary research interest is genetics and epigenetics as they relate to lung health, lung disease and intersections with sex, gender and aging. To pursue her interest in understanding COPD susceptibility, including the role of genetics and epigenetics in early-onset COPD and sex differences, she has been the recipient of grants from the National Institutes of Health, the American Lung Association and the Alpha 1 Foundation. Dr. DeMeo’s vision includes streamlining effective multidisciplinary care for complex diseases through careful scientific investigations, with an eventual goal of designing and implementing genomic insights into diagnostics, therapeutics, and preventative strategies for diseases especially COPD, informed by “Big Data” and Network Medicine approaches inclusive of age, sex and gender aware approaches.